Piramal Pharma Ltd: Piramal Pharma Limited Announces Results for Q3 and 9M FY25
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...
Krone8 小时
After a one-way deposit, will there now be a levy on rechargeable batteries?
Hot topics will be discussed tomorrow, Thursday, in the Upper Austrian state parliament: The SPÖ wants to introduce a deposit ...
Piramal Pharma Limited Announces Results for Q3 and 9M FY25
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...
Piramal Pharma Q3 PAT drops 64% YoY to Rs 4 crore
The pharmaceutical company's consolidated net profit tumbled 63.6% to Rs 3.68 crore despite of 12.54% increase in revenue from operations to Rs 2,204.22 crore in Q3 FY25 over Q3 FY24.